Self-repopulating recipient bone marrow resident macrophages promote long-term hematopoietic stem cell engraftment

Simranpreet Kaur1,2, Liza J Raggatt1,2, Susan M Millard1,2

  • 1Mater Research Institute-The University of Queensland, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.

Blood
|June 28, 2018
PubMed

Insights

Resident macrophages in bone marrow are crucial for successful hematopoietic stem cell transplantation. Depleting these cells impairs stem cell engraftment and hematopoietic recovery, highlighting their importance in transplantation outcomes.

Area of Science:

  • Immunology
  • Hematology
  • Stem Cell Biology

Background:

  • Resident tissue macrophages play key roles in maintaining the hematopoietic stem cell niche and supporting erythropoiesis.
  • Understanding macrophage subset dynamics post-transplantation is critical for improving hematopoietic stem cell transplantation (HSCT) outcomes.

Purpose of the Study:

  • To investigate the persistence and function of distinct bone marrow and splenic macrophage subsets after lethal irradiation and autologous HSCT in mice.
  • To determine the role of recipient-derived macrophages in hematopoietic reconstitution and stem cell engraftment.

Main Methods:

  • Utilized a myeloid reporter gene (Csf1r-eGFP) to track macrophage populations in a mouse model.
  • Analyzed macrophage subset survival and repopulation kinetics in bone marrow and spleen post-HSCT.
  • Assessed the impact of selective CD169+ macrophage depletion on stem cell engraftment and hematopoietic reconstitution.

Main Results:

  • Multiple recipient macrophage subsets exhibited organ-specific survival and persistence post-HSCT.
  • Bone marrow CD169+ resident macrophages and erythroid-island macrophages self-repopulated long-term through cell division.
  • Depletion of recipient CD169+ macrophages significantly impaired long-term HSC engraftment and overall hematopoietic reconstitution.

Conclusions:

  • Recipient bone marrow resident macrophages, particularly CD169+ cells, are essential for optimal HSCT success.
  • These macrophages are critical for the engraftment of long-term reconstituting HSCs.
  • Targeting or preserving recipient macrophages could be a valuable strategy for enhancing HSCT therapies.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.3K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.9K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.5K